High disabled and LD deaths
February 17, 2021
166,627
5,970
2,931
5.34%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr John Campbell Episodes Around February 17, 2021
See what was published immediately before and after this episode.
33:12Now PlayingHigh disabled and LD deaths
YouTube Description
as posted by the channelUS
Storms
Federal vaccination centres open
Doses given, 55,792,000
Second dose, 15,192,000 (4.65%)
Hospitalizations, 64,535
Past 7 days
New daily reported cases, down 23.7%
New daily reported deaths, down 7.6%
CoViD related hospitalizations, down 18.4%
Test positivity rate, 5.5%
ONS data
Antibodies to COVID-19
28 days up to 1st February
England
18.5% of the population
8.3 million people aged 16 years and over
Over 80 years, 40.9%
Wales
14.4%
Northern Ireland
13.6%
Scotland
11.7%
Cases, W/E 6th February
England
Prevalence, 1 in 80
Equating to 695,400 people
(W/E 30th January, 846,900 people)
Wales
One in 85
Northern Ireland
One in 75 people
Scotland
One in 150 people
Deaths, W/E 5th February
+ 7,320 for the week
Down 1,113 deaths compared with the previous week
COVID-19 still accounted for 42.6% of all deaths in England and Wales
Disabled people
24 January to 20 November 2020
At greater risk of death
Men
Not disabled x 1
Disabled x 1.9
More disabled x 3.1
Women
Not disabled x 1
Disabled x 2
More disabled x 3.5
Learning disability, risk of death
Age adjusted risk, x 3.5
Zimbabwe, vaccine
Monday, 200 000 doses of vaccines donated by China
600 000 doses to arrive next month
Vaccines from Russia, India, United Kingdom on their way
79.34%
2 doses, 3 weeks apart
Beijing Institute of Biological Products
Inactivated coronavirus vaccine
Approved in China, UAE, Hungary
China, 1 million doses given
No phase 3 publication
Ongoing in UAE, Morocco, Peru
UAE, full approval, 86%
Chinese researchers, tested against variant B.1.351
Antibody response, only modestly weaker
Not yet published
Israel
SA variant, 44
Reinfections with SA variant, 3
Government, planning to launch a green certificate
Enable vaccine recipients to enter public spaces, stadiums, concert halls, performance venues
Purim on Feb. 25
France
SA and Brazil variants, 5% of cases
Mostly in east
More vaccination doses sent
WHO approved vaccines
Covax programme
Pfizer
Oxford AZ, India
Oxford AZ, South Korea
All adults, all ages
150 million doses of AZ, first quarter
2 billion vaccine doses this year
92 lower income countries
Dr Alejandro Cravioto, WHO's Strategic Advisory Group of Experts on Immunization
There is no reason not to recommend its use even in countries that have circulation of the variant
Tim Spector
450,000 first vaccine logs
Even split, Pfizer and AZ
Side effects
Pfizer, under 15% systemic symptoms
Both vaccines, higher if people have had the infection
More reactions younger and female
May not want to be having the vaccine within a few months of infection
May not need a vaccine this round
AZ
Less arm pain
More systemic side effects
Twice as many people report systemic side effects
One to two days
Mild allergic reactions
Pfizer, 1%
AZ, 2.5%
Rashes
Swelling of the eyes
Fairly reassuring
Levels of protection (Pfizer only so far)
No protection at all for 13 days
21 to 30 days for full protection
68% reduction in new infections
Less severe disease if infected
Australia
Case by case, individual clinical discretion
No efficacy issue in older people, just a possible futility issue for a small number
Measured approach, 91% vaccine acceptance
Dr Susan
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.